SIPAI HEALTH TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.9 USD | 0.00% |
|
+1.20% | -14.49% |
| Mar. 19 | Sipai Health Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 05 | Sipai Health Technology Expects to Narrow Loss in Full Year 2023 | MT |
| Sales 2024 * | 5.2B 717M | Sales 2025 * | 5.9B 814M | Capitalization | 4.15B 573M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.74 x |
| Net cash position 2024 * | 284M 39.25M | Net cash position 2025 * | 200M 27.59M | EV / Sales 2025 * | 0.67 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 3,089 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 30.93% |
More Fundamentals
* Assessed data
More news
| 1 week | +1.20% | ||
| Current month | -1.99% | ||
| 1 month | -2.48% | ||
| 3 months | -8.24% | ||
| 6 months | -21.33% | ||
| Current year | -14.49% |
1 week
5.68
6.06
1 month
5.566.40
Current year
5.568.60
1 year
4.8942.65
3 years
4.8944.60
5 years
4.8944.60
10 years
4.8944.60
| Managers | Title | Age | Since |
|---|---|---|---|
Ji Li
FOU | Founder | 46 | 15-05-18 |
Xu Guang Ma
CEO | Chief Executive Officer | 53 | 14-02-28 |
Qi Ang Li
COO | Chief Operating Officer | 42 | 19-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Fan Xin
BRD | Director/Board Member | 45 | 23-05-09 |
Xu Guang Ma
CEO | Chief Executive Officer | 53 | 14-02-28 |
Ji Li
FOU | Founder | 46 | 15-05-18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 5.9 | 0.00% | 344 400 |
| 24-04-23 | 5.9 | -1.67% | 627,200 |
| 24-04-22 | 6 | +0.84% | 742,200 |
| 24-04-19 | 5.95 | -0.50% | 816,200 |
| 24-04-18 | 5.98 | +1.87% | 1,079,000 |
End-of-day quote Hong Kong S.E., April 23, 2024
More quotes
Sipai Health Technology Co Ltd is principally engaged in providing medical and health services. The Company's businesses include Specialty Pharmacy Business, Physician Research Assistance Business and Health Insurance Services Business. Specialty Pharmacy Business includes the operation of offline specialty pharmacies and distribution of pharmaceutical products to pharmaceutical companies and other distributors. Physician Research Assistance Business mainly provides integrated services for pharmaceutical companies to assist them in producing clinical trial data that meets the relevant regulatory standards for the pharmaceutical companies to advance to the next phase of clinical or solicit approval of a treatment by the applicable regulatory body. Health Insurance Services Business provides insurance brokerage services including distribution of various health and life insurance products on behalf of insurance carriers.
Sector
Drug Retailers
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
5.458
CNY
Average target price
7.893
CNY
Spread / Average Target
+44.61%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -14.49% | 573M | |
| -32.06% | 15.57B | |
| -36.19% | 9.81B | |
| +9.74% | 6.08B | |
| -10.45% | 6.03B | |
| -35.14% | 5.52B | |
| -0.73% | 4.75B | |
| +52.93% | 4.23B | |
| -12.02% | 3.6B | |
| -5.68% | 3.16B |
- Stock Market
- Equities
- 314 Stock
